Pacala Mark L — SEC Form 4 filings

SEC reporting owner CIK 1321250. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-11-18 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oncology Institute, Inc. (TOI)Director61 leg · 90,562 sh · $94,3383 legs · 50,000 sh · $200,0007

Form 4 filings — Pacala Mark L

FiledFormIssuerReported transactionsSource
2026-07-294Oncology Institute, Inc. (TOI)Grant/award (A): 30,120 @ $0EDGAR
2025-11-244Oncology Institute, Inc. (TOI)Grant/award (A): 46,296 @ $0 · Grant/award (A): 35,494 @ $0EDGAR
2025-11-204Oncology Institute, Inc. (TOI)Sale (S): 2,160 @ $4 · Sale (S): 1,210 @ $4 · Sale (S): 46,630 @ $4EDGAR
2025-03-284Oncology Institute, Inc. (TOI)Purchase (P): 90,562 @ $1.04 · Purchase (P): 42,281 (derivative) @ $0.12EDGAR
2024-11-254Oncology Institute, Inc. (TOI)Grant/award (A): 50,000 @ $0EDGAR
2024-11-184Oncology Institute, Inc. (TOI)Other (J): 20,248 @ $0 · Other (J): 30,372 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1321250 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →